Postdoctoral Fellow | Chemical Biology/RNA Biol...

We are recruiting candidates for a fully funded postdoctoral position in the Meier Laboratory at the National Cancer Institute, NIH located in Frederick, MD. Our research focuses on understanding the role of chemical modifications in gene expression control, with the goal of defining new targets for cancer treatment. Recent advances span RNA modification biology to epigenetic drug discovery, and include defining RNA acetylation as a gene regulatory mechanism (Sci Adv, NAR, Cell 2025) and characterizing first-in-class HAT inhibitors (JACS Au 2024, BioRxiv 2025). We have a strong track record of designing high-impact projects with clear publication pathways that serve the NCI’s mission and the career development of our trainees.

For this posting, we are seeking candidates interested in advancing one or more of the following areas: 1) RNA modification biology and sequencing technology development, 2) chemical proteomics and epigenetic drug discovery, and/or 3) high-throughput and massively parallel approaches to studying modification function. Competitive candidates will have a strong background in molecular biology, RNA biology, chemical biology, or a related discipline. Experience with sequencing-based assays or chemoproteomic methods is a plus.

We are part of the Chemical Biology Laboratory, an integrated and collegial unit comprising seven research groups located on the NCI’s Frederick, MD campus, and benefit from the exceptional scientific environment and collaborative opportunities of the NIH Intramural Research Program. The NIH offers highly competitive postdoctoral stipends, comprehensive federal benefits for fellows and dependents, and J-1 visa sponsorship for international applicants. Fellowships are supported by generous core funding and are renewable for up to five years. International scientists and U.S. citizens are equally eligible.

Interested candidates should send a letter of interest, CV, and contact information for two references directly to Jordan Meier.

Additional information:PI website: />Recent publications:  Tagged as: Life Sciences